Navigation Links
National Pharmaceutical Council Welcomes Shire as Its Newest Member
Date:8/3/2011

WASHINGTON, Aug. 3, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today welcomed global specialty biopharmaceutical company Shire plc as a new member. Dr. Jeffrey M. Jonas, senior vice president, specialty pharma R&D, will serve as Shire's representative on the NPC board of directors.

"The last few years have brought change to the health care environment that has left many important questions unresolved.  For the pharmaceutical industry, how comparative effectiveness research will be conducted and used is critical. We welcome Shire and look forward to their contribution to our shared mission of helping to answer these questions and chart the future," said NPC President Dan Leonard.

Shire, with facilities in Pennsylvania and Massachusetts, is focused on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. 

"Shire is very supportive of NPC's focus on evidence-based medicine and on policy research related to comparative effectiveness research, pharmaceutical innovation and the value of medicines," said Dr. Jonas. "We're pleased to be a part of this organization and look forward to working with NPC on issues affecting the pharmaceutical industry."

In becoming an NPC member, Shire joins with other leading research-based pharmaceutical companies, including Abbott Laboratories, Astra Zeneca LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc., Pfizer Inc, sanofi-aventis, and Teva Neuroscience.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International
2. FDA, International Counterparts Report Progress on Drug Inspection Collaboration
3. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
4. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
5. Elsevier Supports International Medical Corps Through Act to Save a Life Campaign
6. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
7. H. D. Smith Reorganizes National Leadership for Continued Focus on Regional Customer Needs; Support Company Growth
8. Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference
9. Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology
10. Epitomics Releases New Antibodies Developed With the National Cancer Institutes Center for Cancer Research
11. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):